Home LiteratureArticle Details
PMID: 15117455 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.

AIDS research and human retroviruses ·Vol. 20 ·No. 3 ·2004-03-00 ·Pages 315-25

Norris PJ, Moffett HF, Brander C, Allen TM, O'Sullivan KM, Cosimi LA, Kaufmann DE, Walker BD, Rosenberg ES

Abstract

Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.

MeSH Terms
Amino Acid Sequence CD4-Positive T-Lymphocytes/immunology Clone Cells Cross Reactions Epitope Mapping Epitopes, T-Lymphocyte/chemistry,immunology HIV Core Protein p24/chemistry,genetics,immunology HIV Infections/immunology,virology HIV-1/chemistry,genetics,immunology Humans Interferon-gamma/metabolism Lymphocyte Activation Molecular Sequence Data Peptides/chemistry,pharmacology
Chemicals
Epitopes, T-Lymphocyte HIV Core Protein p24 Peptides Interferon-gamma
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Norris Philip J
Partners AIDS Research Center and Infectious Disease Unit, The Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. [email protected]
Moffett Howell F
Brander Christian
Allen Todd M
O'Sullivan Kristin M
Cosimi Lisa A
Kaufmann Daniel E
Walker Bruce D
Rosenberg Eric S
References (59)
59 references, click to expand
  1. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Nature. 2002 Nov 28;420(6914):434-9 PMID: 12459786
  2. Examination of the highly diverse CD4(+) T-cell repertoire directed against an influenza peptide: a step towards TCR proteomics.
    Immunogenetics. 2002 Dec;54(9):611-20 PMID: 12466894
  3. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
    J Immunol. 2003 Jan 15;170(2):1106-16 PMID: 12517980
  4. Evaluation of antigen-specific responses using in vitro enriched T cells.
    J Immunol Methods. 2003 Mar 1;274(1-2):139-47 PMID: 12609540
  5. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens.
    J Immunol. 1987 Aug 15;139(4):1369-74 PMID: 3112233
  6. The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.
    J Immunol. 1988 Jul 15;141(2):377-82 PMID: 2454990
  7. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion.
    Cell. 1988 Aug 12;54(4):561-75 PMID: 2969774
  8. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones.
    J Immunol. 1989 Nov 1;143(9):2814-9 PMID: 2478626
  9. Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type.
    Mol Immunol. 1990 Oct;27(10):941-6 PMID: 1700286
  10. T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides.
    Eur J Immunol. 1991 Jan;21(1):1-10 PMID: 1703959
  11. T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes.
    J Exp Med. 1991 Mar 1;173(3):609-17 PMID: 1705279
  12. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
    J Immunol. 1991 Sep 1;147(5):1512-21 PMID: 1715361
  13. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.
    Science. 1991 May 31;252(5010):1308-10 PMID: 1833816
  14. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.
    Cell. 1992 Feb 21;68(4):625-34 PMID: 1739971
  15. Functional consequences of engagement of the T cell receptor by low affinity ligands.
    J Immunol. 1993 Jan 1;150(1):1-7 PMID: 8417115
  16. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    J Exp Med. 1993 Apr 1;177(4):1047-60 PMID: 8384651
  17. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
    Eur J Immunol. 1993 May;23(5):1011-6 PMID: 8386663
  18. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
    J Immunol. 1993 May 15;150(10):4277-83 PMID: 8482836
  19. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.
    J Exp Med. 1994 Jun 1;179(6):1945-56 PMID: 7515103
  20. Natural amino acid polymorphisms of the circumsporozoite protein of Plasmodium falciparum abrogate specific human CD4+ T cell responsiveness.
    Eur J Immunol. 1994 Jun;24(6):1418-25 PMID: 7911423
  21. Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells.
    J Virol. 1994 Dec;68(12):7704-8 PMID: 7525983
  22. Specific incorporation of cyclophilin A into HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):359-62 PMID: 7969494
  23. Differential activation of mouse hepatitis virus-specific CD4+ cytotoxic T cells is defined by peptide length.
    Immunology. 1995 Aug;85(4):517-22 PMID: 7558143
  24. CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):128-36 PMID: 8556394
  25. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
    J Virol. 1996 Jun;70(6):3551-60 PMID: 8648689
  26. Yersinia-hsp60-reactive T cells are efficiently stimulated by peptides of 12 and 13 amino acid residues in a MHC class II (I-Ab)-restricted manner.
    Clin Exp Immunol. 1996 Aug;105(2):231-7 PMID: 8706327
  27. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A.
    J Virol. 1996 Aug;70(8):5170-6 PMID: 8764025
  28. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    J Immunol. 1997 Jan 15;158(2):807-15 PMID: 8992998
  29. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401 PMID: 9037064
  30. CD4+ T-cell recognition of diverse clade B HIV-1 isolates.
    AIDS. 1997 Mar;11(3):281-8 PMID: 9147418
  31. The puzzle of HIV-1 subtypes in Africa.
    AIDS. 1997 May;11(6):705-12 PMID: 9143601
  32. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine.
    Gastroenterology. 1997 Jun;112(6):2017-27 PMID: 9178695
  33. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
    Immunity. 1997 Sep;7(3):387-99 PMID: 9324359
  34. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
    J Virol. 1997 Nov;71(11):8615-23 PMID: 9343219
  35. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.
    J Virol. 1997 Nov;71(11):8908-11 PMID: 9343257
  36. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  37. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    AIDS. 1998 Apr 16;12(6):571-9 PMID: 9583596
  38. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni.
    J Immunol. 1998 Jun 1;160(11):5420-7 PMID: 9605143
  39. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells.
    J Immunol. 1998 Jun 15;160(12):5807-14 PMID: 9637491
  40. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
    Virology. 1998 Oct 25;250(2):316-24 PMID: 9792842
  41. Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.
    J Infect Dis. 1998 Oct;178(4):1040-6 PMID: 9806032
  42. HIV-1 variation diminishes CD4 T lymphocyte recognition.
    J Exp Med. 1998 Nov 16;188(10):1785-93 PMID: 9815256
  43. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.
    J Virol. 1999 Feb;73(2):1708-14 PMID: 9882385
  44. Immunoregulation of Th cells by naturally processed peptide antagonists.
    J Immunol. 1999 Jan 1;162(1):1-4 PMID: 9886362
  45. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum.
    Immunity. 1999 Jun;10(6):651-60 PMID: 10403640
  46. Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones.
    J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):1-7 PMID: 10708050
  47. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.
    J Virol. 2000 May;74(9):4361-76 PMID: 10756051
  48. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    J Virol. 2000 Sep;74(18):8541-9 PMID: 10954555
  49. T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune).
    Clin Diagn Lab Immunol. 2000 Sep;7(5):724-7 PMID: 10973444
  50. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
    Nature. 2000 Sep 21;407(6802):386-90 PMID: 11014195
  51. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda.
    J Infect Dis. 2000 Nov;182(5):1350-6 PMID: 11023458
  52. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
    J Virol. 2001 May;75(9):4195-207 PMID: 11287569
  53. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
    J Immunol. 2001 Jun 1;166(11):6720-7 PMID: 11359828
  54. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Eur J Immunol. 2001 Jun;31(6):1747-56 PMID: 11385619
  55. Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.
    J Virol. 2001 Oct;75(20):9771-9 PMID: 11559810
  56. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.
    J Immunol. 2002 Mar 15;168(6):3099-104 PMID: 11884484
  57. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues.
    J Immunol. 2002 Jul 15;169(2):739-49 PMID: 12097376
  58. Direct ex vivo analysis of human CD4(+) memory T cell activation requirements at the single clonotype level.
    J Immunol. 2002 Aug 1;169(3):1207-18 PMID: 12133941
  59. Enhancement of MHC class II-restricted responses by receptor-mediated uptake of peptide antigens.
    J Immunol. 2002 Sep 1;169(5):2337-45 PMID: 12193699
Article Info
Journal
AIDS research and human retroviruses
Abbr.
AIDS Res Hum Retroviruses
ISSN
0889-2229
Published
2004-03-00
Pages
315-25
Language
English
Region
United States
NLM ID
8709376
PMCID
PMC2553686
Subset
IM
Grants
NIAID NIH HHS · R01 AI040873 · United States
NIAID NIH HHS · K08 AI001698-04 · United States
NIAID NIH HHS · K08 AI001698 · United States
NIAID NIH HHS · AI40873 · United States
NIAID NIH HHS · AI01698 · United States
NIAID NIH HHS · R21 AI040873 · United States
Databases
GENBANK
AF073420, AF073421, AF073422, AF073423
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]